{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:49:04Z","timestamp":1792291744152,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4265,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1093\/annonc\/mdm460","type":"journal-article","created":{"date-parts":[[2007,10,5]],"date-time":"2007-10-05T20:34:20Z","timestamp":1191616460000},"page":"607-613","source":"Crossref","is-referenced-by-count":107,"title":["Emerging therapeutic options for breast cancer chemotherapy during pregnancy"],"prefix":"10.1016","volume":"19","author":[{"given":"O.","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Berveiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ropert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goffinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Treluyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm460_bb0010","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/annonc\/mdi388","article-title":"Breast cancer and pregnancy","volume":"16","author":"Ring","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.21610","article-title":"Breast carcinoma during pregnancy. International recommendations from an expert meeting","volume":"106","author":"Loibl","year":"2006","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","article-title":"Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients","volume":"15","author":"Germann","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0025","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1200\/JCO.2005.03.038","article-title":"Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals","volume":"23","author":"Ring","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0030","series-title":"Cancer Chemotherapy and Biotherapy","first-page":"237","article-title":"Antimicrotubule agents","author":"Rowinsky","year":"2006"},{"key":"10.1093\/annonc\/mdm460_bb0035","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.21070","article-title":"Women age < or = 35 years with primary breast carcinoma: disease features at presentation","volume":"103","author":"Gonzales-Angulo","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1006\/gyno.2001.6439","article-title":"Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy","volume":"83","author":"Sood","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0045","first-page":"1200","article-title":"Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer","volume":"102","author":"Mendez","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdm460_bb0050","first-page":"5225","article-title":"Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature","volume":"23","author":"Gadducci","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdm460_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3816\/CBC.2004.n.037","article-title":"Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer","volume":"5","author":"Gonzalez-Angulo","year":"2004","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1470-2045(06)71014-2","article-title":"Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy","volume":"8","author":"Bader","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejogrb.2006.04.006","article-title":"Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review","volume":"131","author":"Mantovani","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1093\/annonc\/mdm460_bb0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3816\/CBC.2006.n.049","article-title":"Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report","volume":"7","author":"Lycette","year":"2006","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-007-0328-2","article-title":"Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma","author":"Hubalek","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1093\/annonc\/mdm460_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/j.1525-1438.2007.00917.x","article-title":"Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review","author":"Modares-Gilani","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2354.2000.00231.x","article-title":"Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel","volume":"9","author":"De Santis","year":"2000","journal-title":"Eur J Cancer Care"},{"key":"10.1093\/annonc\/mdm460_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clon.2005.12.002","article-title":"Breast cancer in pregnancy: are taxanes safe?","volume":"18","author":"Gainford","year":"2006","journal-title":"Clin Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3816\/CBC.2006.n.029","article-title":"Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature","volume":"7","author":"Potluri","year":"2006","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3816\/CBC.2006.n.008","article-title":"Docetaxel administered during pregnancy for inflammatory breast carcinoma","volume":"6","author":"Nieto","year":"2006","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.AOG.0000267133.65430.44","article-title":"Trastuzumab use for breast cancer in pregnancy","volume":"110","author":"Sekar","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdm460_bb0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0959-8049(96)00356-5","article-title":"Vinorelbine in pregnancy","volume":"33","author":"Cuvier","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000055371","article-title":"Chemotherapy for a patient with advanced non-small cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy","volume":"61","author":"J\u00e4nne","year":"2001","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdm460_bb0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3816\/CBC.2005.n.040","article-title":"Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy","volume":"6","author":"Fanale","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.AOG.0000141570.31218.2b","article-title":"Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios","volume":"105","author":"Watson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdm460_bb0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1200\/JCO.2005.04.6607","article-title":"Effect of adjuvant trastuzumab on pregnancy","volume":"24","author":"Waterston","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.reprotox.2007.02.003","article-title":"Favorable pregnancy outcome after trastuzumab (herceptin) use during pregnancy. Case report and updated literature review","volume":"23","author":"Shrim","year":"2007","journal-title":"Reprod Toxicol"},{"key":"10.1093\/annonc\/mdm460_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3816\/CBC.2006.n.048","article-title":"Delivery of a healthy baby after first-trimester maternal exposure to lapatinib","volume":"7","author":"Kelly","year":"2006","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mdm460_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1040-8428(94)90043-4","article-title":"Pharmacology of antineoplastic agents in pregnancy","volume":"16","author":"Wiebe","year":"1994","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdm460_bb0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1022381506823","article-title":"US singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender","volume":"3","author":"Alexander","year":"1999","journal-title":"Matern Child Health J"},{"key":"10.1093\/annonc\/mdm460_bb0155","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(07)70242-5","article-title":"Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy","volume":"8","author":"Robinson","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdm460_bb0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00008571-199712000-00002","article-title":"Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo\/in-vitro correlation and inducibility","volume":"7","author":"Treluyer","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1093\/annonc\/mdm460_bb0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","article-title":"Designing pregnancy centered medications: drugs which do not cross the human placenta","volume":"27","author":"Gedeon","year":"2006","journal-title":"Placenta"},{"key":"10.1093\/annonc\/mdm460_bb0170","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"Smit","year":"1999","journal-title":"J Clin Invest"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419414336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419414336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/4\/607\/578299\/mdm460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T08:24:29Z","timestamp":1582187069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419414336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0923753419414336"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm460","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120140.576286","asserted-by":"object"}]},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}